These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Results of treatment in patients with hairy cell leukemia with splenectomy, alpha-interferon and deoxycoformycin]. Gotić M, Rolović Z, Radosević N, Draguljac N, Jovanović V, Bogdanović A, Bosković D. Srp Arh Celok Lek; 2000; 128(7-8):262-70. PubMed ID: 11089434 [Abstract] [Full Text] [Related]
8. [Hairy cell leukemia]. Ujj G, Telek B, Kiss A, Rák K. Orv Hetil; 1989 Aug 27; 130(35):1867-70. PubMed ID: 2797783 [Abstract] [Full Text] [Related]
9. [Hairy-cell leukemia: analysis of 11 cases]. Montserrat E, Boccia A, Feliu E, Urbano-Ispizua A, Campo E, Brugués R, Rozman C. Sangre (Barc); 1988 Apr 27; 33(2):108-13. PubMed ID: 3400000 [No Abstract] [Full Text] [Related]
13. Cladribine (2-chlorodeoxyadenosine) therapy in hairy cell leukemia variant. A report of three cases. Palomera L, Domingo JM, Sola C, Azaceta G, Calvo MT, Gutierrez M. Haematologica; 2002 Jan 27; 87(1):107-8. PubMed ID: 11801472 [No Abstract] [Full Text] [Related]
14. [Case report on the diagnosis and therapy of hairy-cell leukemia]. Atanasov K, Dincheva K. Vutr Boles; 1987 Jan 27; 26(1):101-5. PubMed ID: 3590717 [Abstract] [Full Text] [Related]
16. Hairy-cell leukemia and toxoplasmosis. Chrobák L, Bostíková D, Mirová S, Hozák A, Radochová D. Neoplasma; 1982 Jan 27; 29(4):487-92. PubMed ID: 7133241 [Abstract] [Full Text] [Related]
17. [Hairy cell leukemia successfully treated with 2'-deoxycoformycin following refractoriness to splenectomy and alpha-interferon therapy]. Shibata T, Hotta T. Rinsho Ketsueki; 1992 Feb 27; 33(2):216-20. PubMed ID: 1635172 [Abstract] [Full Text] [Related]
18. Hairy cell leukemia. A therapeutical update. Damasio EE, Pagnucco G, Federico M, Annino L, Chisesi T, Lamparelli T, Lauria F, Castoldi G, Resegotti L. Haematologica; 1989 Feb 27; 74(2):205-18. PubMed ID: 2473014 [Abstract] [Full Text] [Related]
19. Splenectomy followed by administration of rituximab is useful to treat a patient with hairy cell leukemia-variant. Yoshida T, Mihara K, Sugihara S, Arihiro K, Mino T, Sasaki N, Takihara Y. Ann Hematol; 2013 May 27; 92(5):711-3. PubMed ID: 23183878 [No Abstract] [Full Text] [Related]
20. [Successful use of vemurafenib in a patient with resistant hairy cell leukemia]. Urnova ES, Al'-Radi LS, Kuz'mina LA, Kariakina AA, Kovrigina AM, Dvirnyk VN, Iakutik IA, Sudarikov AB, Parovichnikova EN, Savchenko VG. Ter Arkh; 2013 May 27; 85(7):76-8. PubMed ID: 24137951 [Abstract] [Full Text] [Related] Page: [Next] [New Search]